Growth Metrics

Lensar (LNSR) Current Leases (2020 - 2026)

Lensar (LNSR) reported Current Leases of $785000.0 for Q1 2026, up 51.84% year-over-year from $517000.0 in Q1 2025, and up 5.09% on a QoQ basis from $747000.0 in Q4 2025.

Lensar (LNSR) has 7 years of Current Leases data on file, last reported at $785000.0 in Q1 2026.

  • Quarterly Current Leases rose 51.84% year-over-year to $785000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $785000.0 (up 51.84% YoY) and the FY2025 annual result came in at $747000.0, up 42.56% from the prior year.
  • Current Leases improved to $785000.0 in Q1 2026 per LNSR's latest filing, from $747000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $785000.0 in Q1 2026 and bottomed at $516000.0 in Q1 2022.
  • The 5-year median for Current Leases is $549000.0 (2023), against an average of $576176.5.
  • The widest annual swing landed in 2025, when Current Leases decreased 8.33%; it then jumped 51.84% in 2026.
  • Tracing LNSR's Current Leases over 5 years: stood at $531000.0 in 2022, then climbed by 5.27% to $559000.0 in 2023, then slipped by 6.26% to $524000.0 in 2024, then jumped by 42.56% to $747000.0 in 2025, then climbed by 5.09% to $785000.0 in 2026.
  • Per Business Quant, the three latest LNSR Current Leases figures stand at $785000.0 (Q1 2026), $747000.0 (Q4 2025), and $693000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Lensar 69.32 Mn 69.61 Mn 6.38 Mn 785,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 785,000.00
Dec 31, 2025 747,000.00
Sep 30, 2025 693,000.00
Jun 30, 2025 522,000.00
Mar 31, 2025 517,000.00
Dec 31, 2024 524,000.00
Sep 30, 2024 574,000.00
Jun 30, 2024 569,000.00
Mar 31, 2024 564,000.00
Dec 31, 2023 559,000.00
Sep 30, 2023 554,000.00
Jun 30, 2023 549,000.00
Mar 31, 2023 544,000.00
Dec 31, 2022 531,000.00
Sep 30, 2022 526,000.00
Jun 30, 2022 521,000.00
Mar 31, 2022 516,000.00
Dec 31, 2021 512,000.00
Dec 31, 2020 493,000.00